Johnson & Johnson reports Q1 2026 results, raises 2026 outlook 2026 First-Quarter reported sales growth of 9.9% to $24.1 Billion with operational growth of 6.4% and adjusted operational growth of 5.3% 2026 First-Quarter earnings per share (EPS) of $2.14 and adjusted EPS of $2.70 Company increases 2026 guidance with estimated reported sales of $100.8 Billion or 7.0% at the ...

Explore Johnson & Johnson's corporate information, financial updates, and investor resources on this comprehensive platform.

The brother of Johnson & Johnson cofounders Robert Wood Johnson and James Wood Johnson, Edward Mead Johnson led the company’s sales and marketing division in the 19 th century. In 1898, Edward Mead left Johnson & Johnson, taking with him the company’s digestive products line, a business that would eventually become a leading global company in the field of infant and child nutrition.

NEW BRUNSWICK, N.J.-- (BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full-year 2025. “2025 was a catapult year for Johnson & Johnson, fueled by the strongest portfolio and pipeline in our history,” said Joaquin Duato, Chairman and Chief Executive Officer, Johnson & Johnson. “Last year kicked off a new era of accelerated growth, driven by ...

This morning, Johnson & Johnson shared its first-quarter 2026 earnings report. Since its founding in 1886, the company has been committed to innovation—today, approximately 140,000 employees across the globe work to deliver solutions for patients around the world to help profoundly impact health for humanity. “ Johnson & Johnson delivered a solid quarter while advancing our portfolio and ...